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REGULATORY IMPLICATIONS OF THE COMPREHENSIVE CARE 
FOR JOINT REPLACEMENT DEMONSTRATION PROJECT 
THOMAS W. BREWER* 
ABSTRACT 
An often overlooked provision in the Patient Protection and Affordable Care 
Act is the authorization of demonstration projects which incentivize providers to 
develop, implement, and test novel, cost-cutting approaches to care delivery. 
One such project, the Comprehensive Care for Joint Replacement 
demonstration project, encourages providers across the continuum of care to 
collaborate on strategies that improve the quality of and lower the cost of 
complete joint replacements. The project allows providers to share the benefits 
of cost savings, and liabilities for cost overruns, across the surgeons performing 
procedures, acute care facilities, and post-acute care facilities. Arrangements 
of this type, outside of the demonstration project, could potentially expose 
participants to liability under federal laws prohibiting certain financial 
relationships between providers. It is therefore important to understand the 
regulatory implications for the creation and operation of provider networks. It 
is also possible these relationships may need to be unwound if the demonstration 
project were to end. Finally, it is also possible these models may be adopted 
outright and become permanent programs. This article will explore the 
underlying regulatory structure implicated in cost-sharing arrangements with a 
focus on those potential issues implicit in the Comprehensive Care for Joint 
Replacement demonstration project. 
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I.  INTRODUCTION 
Health care is often referred to as the most heavily regulated industry in the 
United States.1 In 2004, the Cato Institute estimated health care regulation to 
cost the average American household more than $1,500 per year.2 While reliable 
estimates related to the effects of regulation on the overall quality of care are 
difficult to find,3 it is nearly axiomatic that regulatory compliance on the part of 
clinicians cuts into valuable time spent with patients.4 One cannot help but 
assume this intrusion has deleterious effects on quality of care as well as patient 
and clinician satisfaction.  
Federal regulations are clearly in the sights of President Trump. He signed 
an Executive Order calling for two federal regulations to be purged for every 
one new regulation promulgated.5 Although it is too soon to fully understand 
how this order will play out, Republican controlled Congress and like-minded 
cabinet secretaries are not expected to offer any substantial pushback.6 
It is certainly not the case that our system of regulation has led the United 
States to be a leader in the efficient delivery of health care. In fact, the United 
States, despite spending the most on health care, both in terms of raw costs7 and 
percent of Gross Domestic Product (GDP),8 lags far behind other modernized 
countries in quality-of-care measures.9 This is not to say that, given the complex 
and fragmented nature of our health care system, we would not be worse off with 
 
 1. An Unhealthy Burden, THE ECONOMIST (June 28, 2007), http://www.economist.com/node 
/9407716 (last visited Jan. 26, 2017); Christopher J. Conover, Health Care Regulation: A $169 
Billion Hidden Tax, POL’Y ANALYSIS, Oct. 4, 2004, at 3. 
 2. Conover, supra note 1, at 1. This estimate is almost certainly inflated due to the inclusion 
of health care services that are required by regulation (such as the cost of actually providing care 
under EMTALA), not merely the costs of the administration of the regulation. 
 3. One report did find an increase in quality metrics from direct clinical regulation for long-
term care residents. See CHARLES PHILLIPS ET AL., REPORT ON THE EFFECTS OF REGULATION ON 
QUALITY OF CARE: ANALYSIS OF THE EFFECT OF REGULATION ON THE QUALITY OF CARE IN 
BOARD AND CARE HOMES 2 (1995). 
 4. Robert I. Field, Why Is Health Care Regulation So Complex?, 33 PHARMACY & 
THERAPEUTICS 607, 607 (2008). 
 5. Exec. Order. No. 13771, 82 Fed. Reg 9,339, 9,339 (Jan. 30, 2017). 
 6. See generally Binyamin Appelbaum & Jim Tankersley, The Trump Effect: Business, 
Anticipating Less Regulation, Loosens Purse Strings, N.Y. TIMES (Jan. 1, 2018), https://www.ny 
times.com/2018/01/01/us/politics/trump-businesses-regulation-economic-growth.html (last visited 
Feb. 5, 2018). 
 7. KAREN DAVIS ET AL., MIRROR, MIRROR ON THE WALL, 2014 UPDATE: HOW THE U.S. 
HEALTH CARE SYSTEM COMPARES INTERNATIONALLY 8 (2014), http://www.commonwealthfund. 
org/publications/fund-reports/2014/jun/mirror-mirror (last visited Jan. 26, 2018). 
 8. David Squires & Chloe Anderson, U.S. Health Care from a Global Perspective: Spending, 
Use of Services, Prices, and Health in 13 Countries, COMMONWEALTH FUND 8 (Oct. 2015), 
http://www.commonwealthfund.org/~/media/files/publications/issue-brief/2015/oct/1819_squires 
_us_hlt_care_global_perspective_oecd_intl_brief_v3.pdf. 
 9. Id. at 7. 
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a more laissez faire regulatory climate, but we should be able to agree that what 
we have now is not producing the kinds of results we would like to see as a 
nation. Moreover, the cost of health care is expected to grow at a rate higher than 
the expansion of the overall economy in the foreseeable future.10 
There have been numerous attempts, with varying levels of success, in the 
past seventy-five years to reform and/or control the cost of health care.11 Riding 
an electoral wave in the 2008 election that brought single-party control to 
Congress and the White House, the Obama administration was able to negotiate 
passage of the most comprehensive health care reform and expansion legislation 
since President Lyndon Johnson’s Great Society created Medicare and 
Medicaid. The Patient Protection and Affordable Care Act (ACA)12 affected 
patients and payors by mandating coverage, emphasizing preventative services, 
expanding public programs such as Medicaid, creating a system of subsidies and 
penalties to incentivize individuals to purchase health care on newly created 
exchanges, and requiring expanded coverage from private insurers.13  
The ACA figured prominently in the political rhetoric of the last presidential 
campaign.14 Although efforts at an immediate “repeal and replace” have stalled, 
it is almost certain that many aspects of this legislation will be modified or 
abandoned under ensuing legislation.15 Despite strong support in some quarters 
for repealing “Obamacare,” many of the law’s constituent parts such as 
protection for care of pre-existing conditions, dependent coverage until age 
twenty-six, and coverage for birth control enjoy broad support.16 This 
conundrum may mean that certain aspects of the law will remain with us for 
some time. Thus, it is still useful to look at the history of the law. 
While the ACA stopped short of introducing a single-payor system, it 
contains multiple provisions aimed at reforming the very structure of health care 
 
 10. See Sean P. Keehan et al., National Health Expenditure Projections, 2015–25: Economy, 
Prices, and Aging Expected to Shape Spending and Enrollment, 35 HEALTH AFF. 1522, 1528 
(2016). 
 11. Catherine Hoffman, National Health Insurance—A Brief History of Reform Efforts in the 
U.S., KAISER FAMILY FOUND. 1 (2009), https://kaiserfamilyfoundation.files.wordpress.com/2013 
/01/7871.pdf. 
 12. Patient Protection and Affordable Care Act, 42 U.S.C. § 18001 (2010). 
 13. Even a cursory discussion of the Affordable Care Act would be well outside the scope of 
this article. See generally Summary of the Affordable Care Act, KAISER FAMILY FOUND. 1–10 
(2013), http://files.kff.org/attachment/fact-sheet-summary-of-the-affordable-care-act. 
 14. PEW RESEARCH CTR., 2016 CAMPAIGN: STRONG INTEREST, WIDESPREAD 
DISSATISFACTION 31 (2016), http://www.people-press.org/2016/07/07/4-top-voting-issues-in-20 
16-election/ (last visited Jan. 17, 2018). 
 15. See Compare Proposals to Replace the Affordable Care Act, KAISER FAMILY FOUND. 
(Sept. 25, 2017), https://www.kff.org/interactive/proposals-to-replace-the-affordable-care-act/ 
(last visited Feb. 5, 2018). 
 16. See id. 
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delivery in the United States.17 One such change is the move toward Medicare 
and Medicaid reimbursement systems that incentivize providers to control costs 
and increase efficiency through collaboration with other providers along the 
continuum of care.18 This provision seeks to move away from traditional fee-
for-service reimbursement that rewards volume over quality and efficiency.19 
The ACA created the Innovation Center within the Centers for Medicare and 
Medicaid Services (CMS) to create, implement, and evaluate new care-delivery 
and payment models.20 One broad category of such innovative models is defined 
as Episode-Based Payment Models (EPM).21 These models, generally speaking, 
hold providers accountable for the price of a course of treatment for some set 
period of time.22 This time period can include the days before a planned 
procedure, such as joint replacement, and continue through the procedure itself 
and subsequent skilled nursing care.23 
EPM, and in fact many of these innovative strategies, are aimed at 
incentivizing business and clinical practice habits that control cost and increase 
quality.24 Unfortunately, the desired behaviors often run counter to practices that 
CMS has worked hard to eliminate, or at least control, in a fee-for-service 
environment.25 The ACA foresaw this inherent tension and granted the Secretary 
of Health and Human Services (HHS) the ability to waive certain aspects of 
fraud and abuse regulation for CMS Innovation Center programs.26 
Providers across the health care continuum are faced with myriad 
uncertainties when operating in this new environment. EPMs and other CMS 
Innovation Center models tend to be quite complex and require coordination 
across numerous providers with varying levels of compliance sophistication. 
The very fact that these programs are experimental in nature adds to the 
 
 17. See id. 
 18. See KAISER FAMILY FOUND., supra note 13, at 10. 
 19. Transitioning to Episode-Based Payment, CTR. FOR HEALTHCARE QUALITY & PAYMENT 
REFORM (Apr. 12, 2009), http://www.chqpr.org/downloads/TransitioningtoEpisodes.pdf. 
 20. About the CMS Innovation Center, CTRS. FOR MEDICARE & MEDICAID SERVS., https://in 
novation.cms.gov/About/index.html (last visited Jan. 18, 2018). 
 21. For a complete list of models, see Innovation Models, CTR. FOR MEDICARE & MEDICAID 
SERVS., https://innovation.cms.gov/initiatives/index.html#views=models (last visited Feb. 8, 
2018). 
 22. Id. 
 23. EPISODE-BASED COST MEASURE DEVELOPMENT FOR THE QUALITY PAYMENT 
PROGRAM, CTRS. FOR MEDICARE & MEDICAID SERVS. 8, 10–11, 14, 26 (2016). 
 24. CTR. FOR HEALTHCARE QUALITY & PAYMENT REFORM, supra note 19. 
 25. THE LEWIN GROUP, CMS BUNDLED PAYMENTS FOR CARE IMPROVEMENT INITIATIVE 
MODELS 24: YEAR 3 EVALUATION & MONITORING ANNUAL REPORT 4–5 (2017), https://down 
loads.cms.gov/files/cmmi/bpci-models2-4yr3evalrpt.pdf. 
 26. Social Security Act § 1115, 42 U.S.C. § 1315a(d)(1) (2012). 
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regulatory uncertainty.27 In some cases, the unknown variable is how a particular 
relationship will evolve throughout the course of the project. Entering into a 
clinical and financial relationship across providers with any measurable degree 
of uncertainty is an anathema to legal and compliance professionals in an 
environment with increased consequences: both financial and potentially 
criminal.28 Programs such as Bundled Payments for Care Improvement (BPCI, 
often referred to as BIP-SEE)29 and Accountable Care Organizations (ACOs)30 
are voluntary and can be entered into with careful organization and regulatory 
planning. Other programs, such as the Comprehensive Care for Joint 
Replacement (CJR) model,31 are mandatory for providers in certain designated 
markets.  
Adding to the complexity is the fact that relationships between providers 
may differ based on the Diagnosis-Related Group (DRG) of the patients they 
share.32 The relationship between an acute and post-acute provider may operate 
under very different sets of regulations at the same time for different patients. 
Finally, an almost constant stream of political rhetoric aimed at repeal of the 
ACA adds another dimension of uncertainty.  
This article will examine the implications of EPMs generally, and the CJR 
model specifically, on fraud and abuse laws. The laws of particular interest are 
the following: Stark Law,33 the Anti-Kickback Statute,34 and the Gainsharing 
Civil Monetary Penalty Law.35 The discussion will highlight areas where the 
CMS waivers fail to insulate participants from exposure to fraud and abuse 
liability for actual or intended conduct under the model. The article will also 
look at how this uncertainty surrounding the actual scope of CMS waivers and 
the overall uncertainty of the regulatory climate suppresses innovation in the 
 
 27. GLEN HEPBURN, ORG. FOR ECON. CO-OPERATION & DEV., ALTERNATIVES TO 
TRADITIONAL REGULATION 11 (2009), http://www.oecd.org/gov/regulatory-policy/42245468.pdf. 
 28. U.S. DEP’T. OF JUSTICE, OFFICE OF THE DEPUTY ATTORNEY GEN., MEMORANDUM TO 
ASSISTANT ATTORNEYS GENERAL, INDIVIDUAL ACCOUNTABILITY FOR CORPORATE 
WRONGDOING 2 (Sept. 9, 2015), https://www.justice.gov/archives/dag/file/769036/download (last 
visited Feb. 8, 2018). 
 29. Laura Dummit et al., Association Between Hospital Participation in a Medicare Bundled 
Payment Initiative and Payments and Quality Outcomes for Lower Extremity Joint Replacement 
Episodes, 316 JAMA 1267, 1267 (2016). 
 30. U.S. DEP’T. OF HEALTH & HUMAN SERVS., CTRS. FOR MEDICARE & MEDICAID SERVS., 
ACO PARTICIPANT LIST AND PARTICIPATION AGREEMENT 2 (2017). 
 31. Comprehensive Care for Joint Replacement Model, CTRS. FOR MEDICARE & MEDICAID 
SERVS., https://innovation.cms.gov/initiatives/cjr (last visited Feb. 5, 2018). 
 32. The DRG system is used by Medicare, as well as some private payors, to classify diagnosis 
for the purposes of reimbursement. Inke Mathauer et al., Hospital Payment Systems Based on 
Diagnosis-Related Groups: Experiences in Low- and Middle-Income Countries, 91 BULL. WORLD 
HEALTH ORG. 746, 746 (2013). 
 33. Also known as physician self-referral. 42 U.S.C. § 1395nn (2012). 
 34. Id. § 1320a-7b. 
 35. Id. §§ 1320a-7a(b)(l), (2). 
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delivery of care and run counter to the stated goal of the program. The article 
will begin with a brief discussion of the evolution of Medicare reimbursement 
from fee-for-service to the current innovation models. The discussion will then 
move to the operation of the CJR model and waivers of certain fraud and abuse 
provisions to allow for foreseeable relationships between providers.  
This is an important topic to explore for several reasons. In order to be truly 
effective, bundled payment models need to foster collaboration and integrated 
delivery of care between and among providers. Although health system 
researchers, and most likely the majority of providers, understand on a 
conceptual level the importance of coordinated care, the realities of a 
decentralized and disjointed system make delivering integrated care difficult. 
Furthermore, fraud and abuse regulations in the United States, which can 
charitably be described as complex, are often suspicious of the types of activities 
undertaken in order to deliver this care. Secondly, the risk to providers is very 
high if they misjudge what is permitted under the demonstration project and 
create an impermissible relationship. This risk would not only be in the form of 
legal liability, but also in opportunity costs they would incur from not building 
stable relationships that would withstand scrutiny moving forward. Finally, it is 
important to understand as much as possible about the potential for liability 
because of the mandatory nature of the program. Unlike voluntary 
demonstration projects where providers can set aside, in advance, the resources 
necessary to build compliant programs, CJR takes a “ready or not” approach to 
participation. This clarity would be especially helpful for smaller providers, such 
as independent skilled nursing facilities (SNFs) who may not have the legal 
resources to make informed decisions regarding their participation. 
II.  MEDICARE REIMBURSEMENT 
Medicare as a source of revenue is extremely important for hospitals and 
physicians. Medicare averages 40.9% of the payor mix in American hospitals.36 
A survey of multispecialty physician practices found the average payor mix 
included thirty-one percent Medicare revenue.37 Given the importance of 
Medicare to the financial health of providers, changes in its reimbursement 
schemes are impossible to ignore. 
Medicare was created in 1965 when President Johnson signed the Title VII 
Amendment to the Social Security Act.38 Originally intended solely for the 
 
 36. Results based on most recently available data from 2009. 60 Things to Know About the 
Hospital Industry | 2016, BECKER’S HOSP. REVIEW (Jan. 14, 2016), https://www.beckershospital 
review.com/lists/50-things-to-know-about-the-hospital-industry-2016.html (last visited Feb. 6, 
2018). 
 37. MED. GROUP MGMT. ASS’N, COST SURVEY: 2014 REPORT BASED ON 2013 DATA 4 
(2014), http://www.mgma.com/Libraries/Assets/Key-Findings-CostSurvey-FINAL.pdf?source. 
 38. Sanaz Hariri et al., Medicare Physician Reimbursement: Past, Present, and Future, 89 J. 
BONE & JOINT SURGERY 2536, 2536 (2007). 
SAINT LOUIS UNIVERSITY SCHOOL OF LAW 
2018] REGULATORY IMPLICATIONS OF THE CJR PROJECT 255 
elderly, Medicare expanded over the years to include other groups (e.g., those 
with end stage renal disease, those receiving disability payments from Social 
Security, and select public employees).39 The range of covered services has also 
expanded to include broader home health services40 and increased access to 
prescription drugs.41 
In an effort to win the backing of wary health care providers, Medicare 
reimbursement was based on exiting fee-for-service models which dominated 
the industry.42 These models reimbursed physicians at a reasonable charge, 
which was defined as the lowest of three possible charges: the actual fee charged 
by the physician, the physician’s customary charge, or some percentage of the 
prevailing charges by other physicians in the area.43 Under this scheme, 
physicians had a financial incentive to raise fees44 and provide more services.45 
Perversely, fee-for-service actually disincentives wellness initiatives as they 
reduce demand for more expensive health care down the road.46  
The cost of Medicare skyrocketed. During the 1980s, the cost of physician 
services rose 13.4% annually.47 By contrast, the United States’ GDP rose an 
average of 3.15% per year during the same time period.48 First, Congress took 
action by pegging reimbursement rates to the actual cost of delivering the 
service.49 Secondly, annual increases in reimbursement rates would be limited 
by a formula which measured the total volume of services provided in the 
previous year.50 In 1997, Congress took further steps to limit the increase in 
physician reimbursement by enacting the Sustainable Growth Rate (SGR).51 The 
SGR attempted to tie the physician fee schedule directly to GDP and limped 
 
 39. Id. 
 40. Medicare and Medicaid Milestones: 1937-2015, CTRS. FOR MEDICARE & MEDICAID 
SERVS. 3 (2015), https://www.cms.gov/About-CMS/Agency-Information/History/Downloads/ 
Medicare-and-Medicaid-Milestones-1937-2015.pdf. 
 41. Id. at 7. 
 42. Hariri et al., supra note 38, at 2537. 
 43. Id. 
 44. Id. 
 45. NETWORK FOR REG’L HEALTHCARE IMPROVEMENT, FROM VOLUME TO VALUE: 
TRANSFORMING HEALTH CARE PAYMENT AND DELIVERY SYSTEMS TO IMPROVE QUALITY AND 
REDUCE COSTS 1 (2009), http://www.nrhi.org/uploads/nrhi-paymentreformprimer.pdf. 
 46. Id. at 4. 
 47. Billy Wynne, May the Era of Medicare’s Doc Fix (1997-2015) Rest In Peace. Now What?, 
HEALTH AFF. BLOG (Apr. 15, 2015), http://healthaffairs.org/blog/2015/04/14/may-the-era-of-
medicares-doc-fix-1997-2015-rest-in-peace-now-what/ (last visited Feb. 6, 2018). 
 48. Kimberly Amadeo, The Strange Ups and Downs of the U.S. Economy Since 1929, THE 
BALANCE (Jan. 26, 2018), https://www.thebalance.com/us-gdp-by-year-3305543 (last visited Feb. 
6, 2018). 
 49. Wynne, supra note 47. 
 50. Id. 
 51. Social Security Act § 1848(f), 42 U.S.C. § 1395w-4, amended by Pub. L. 105-33 111 Stat. 
251 (1997). 
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along until 2003 when it became clear it did not offer sufficient incentive spread 
across a million providers to limit spending.52 At that point, Congress undertook 
a series of short-term, and sometimes shorter-term, patches to prevent physician 
reimbursement rates from falling off a cliff.53 A resolution to this chaotic 
situation came in the form of the Medicare Access and CHIP Reauthorization 
Act of 2015 (MACRA).54 MACRA transitions physicians from fee-for-service 
to reimbursement systems that incentivize quality over volume of care.55 
Physicians can choose reimbursement through Merit-Based Incentive Payment 
System (MIPS)56 or the Alternative Payment Models (APMs) discussed in this 
article.57 
Hospitals share a somewhat parallel history of Medicare reimbursement 
with physicians. Prior to 1983, hospitals were reimbursed retrospectively for 
services provided. The system amounted to fee-for-service with all of the 
associated drawbacks (e.g., cost increases in excess of inflation and limited focus 
on quality).58 In that year, Congress passed the Social Security Amendments of 
1983.59 This legislation was actually one of several steps taken by Congress and 
HHS to move away from retrospective reimbursement.60 What resulted was the 
Prospective Payment System.61 This system bases reimbursement on a DRG for 
inpatient hospital services.62 Each DRG is weighted based on the average 
 
 52. Wynne, supra note 47. 
 53. Had MACRA not been enacted in April 2015, physicians would have faced a 21.2% 
reduction in Medicare reimbursement. See Keith Fontenot et al., A Primer on Medicare Physician 
Payment Reform and the SGR, BROOKINGS (Feb. 2, 2015), https://www.brookings.edu/blog/health 
360/2015/02/02/a-primer-on-medicare-physician-payment-reform-and-the-sgr/ (last visited Feb. 6, 
2018); Wynne, supra note 47; Joshua Hirsch et al., Sustainable Growth Rate Repealed, MACRA 
Revealed: Historical Context and Analysis of Recent Changes in Medicare Physician Payment 
Methodologies, 37 AM. J. NEURORADIOLOGY 210, 211 (2016). 
 54. Medicare Access and CHIP Reauthorization Act of 2015, 42 U.S.C. § 1305 (2015). 
 55. Khaled J. Saleh & William O. Shaffer, Understanding Value-Based Reimbursement 
Models and Trends in Orthopaedic Health Policy: An Introduction to the Medicare Access and 
CHIP Reauthorization Act (MACRA) of 2015, 24 J. AM. ACAD. ORTHOPEDIC SURGERY e136, e137 
(2016). 
 56. Robert B. Doherty, Goodbye, Sustainable Growth Rate—Hello, Merit-Based Incentive 
Payment System, 163 ANNALS INTERNAL MED. 138, 138 (2015). 
 57. Saleh & Shaffer, supra note 55, at e139; STUART GUTERMAN & ALLEN DOBSON, IMPACT 
OF THE MEDICARE PROSPECTIVE PAYMENT SYSTEM FOR HOSPITALS 97 (1986). 
 58. GUTERMAN & DOBSON, supra note 57, at 97. 
 59. Social Security Amendments of 1983, Pub. L. No. 98-21, 97 Stat. 65 (codified as amended 
at 42 U.S.C. § 1395ww(d) (2012)). 
 60. Id. tit. IV; see also GUTERMAN & DOBSON, supra note 57, at 97. 
 61. Prospective Payment Systems – General Information, CTRS. FOR MEDICARE & MEDICAID 
SERVS. (Sept. 6, 2017), https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/Prosp 
MedicareFeeSvcPmtGen/index.html?redirect=/ProspMedicareFeeSvcPmtGen/ (last visited Feb. 8, 
2018). 
 62. Id. 
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resources expended to treat the condition.63 Again, as with physician 
reimbursement, acute care is moving toward APMs that draw focus away from 
volume to value.64  
III.  EPISODE-BASED PAYMENT MODELS 
 As with almost everything related to health care finance, EPMs defy a 
single, parsimonious definition. However, as a practical matter, they involve the 
payor setting a price, or target price, for all services rendered during a specific 
episode of care.65 These models work best in situations where the episode has a 
clear onset and is expected to resolve in a fairly predictable period of time.66 For 
example, complete joint replacement, which will be the subject of this article, is 
a well-defined episode of care. Chronic conditions, such as asthma or cancer, 
are less amenable to this payment scheme.  
In a literal interpretation of the model, the payor would strictly limit 
reimbursement for the set price. Providers who were able to treat the patient for 
less than the price would profit directly from the episode and those who overran 
the set price would be in deficit. The current demonstration projects actually 
operate with somewhat more flexibility. Reimbursement occurs as usual with 
providers—hospitals in this case—receiving bonuses or penalties depending on 
quality, cost, and patient satisfaction.67  
There are several demonstration projects that fall into the broad class of 
EPMs which are sometimes referred to as bundled payment models. One 
example, the BPCI initiative, is composed of four separate models which test 
various permutations of reimbursement schemes.68 Participation in BPCI is 
completely voluntary.  
The CJR model was initiated under Section 3021 of the ACA.69 The model 
tests the role of bundled payments in increasing the quality and lowering the cost 
 
 63. Acute Inpatient PPS, CTRS. FOR MEDICARE & MEDICAID SERVS. (Aug. 2, 2017), 
https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/AcuteInpatientPPS/index. 
html?redirect=/acuteinpatientpps (last visited Feb. 8, 2018). 
 64. BPCI Advanced, CTRS. FOR MEDICARE & MEDICAID SERVS., https://innovation.cms.gov/ 
initiatives/bpci-advanced (last visited Jan. 21, 2018). 
 65. NETWORK FOR REG’L HEALTHCARE IMPROVEMENT, supra note 45, at 7. 
 66. Id. 
 67. Dave Barkholz, Under Construction: Risk-Based Reimbursement, MOD. HEALTHCARE 
(Jun. 18, 2016), http://www.modernhealthcare.com/article/20160618/MAGAZINE/306189982 
(last visited Feb. 8, 2016). 
 68. For example, retrospective bundled payments made for acute care only, retrospective 
bundled payments for acute and post-acute care, retrospective bundled payments made for post-
acute care only, and prospective bundled payments made for acute care only. See Bundled Payments 
for Care Improvement (BPCI) Initiative: General Information, CTRS. FOR MEDICARE & MEDICAID 
SERVS., https://innovation.cms.gov/initiatives/bundled-payments/ (last visited Feb. 8, 2018). 
 69. On September 29, 2016, a letter was sent to the Acting Director of CMS, signed by 179 
Members of Congress, demanding this program be halted. Signatories argued CMS overstepped its 
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of care for Medicare beneficiaries undergoing hip and knee replacements.70 
These conditions were chosen in part because of their impact on the Medicare 
budget. Hip and knee replacements cost the system approximately seven billion 
dollars in hospital care alone each year.71 What makes CJR unique is the fact 
that, unlike BPCI, participation is required for providers in sixty-seven 
Metropolitan Statistical Areas (MSAs).72 The MSAs were purposefully selected 
by CMS to provide an adequate sample across differing sizes and historical 
spending patterns.73 
The demonstration project puts hospitals at the center of the triggering 
episode. Starting April 1, 2016, the cost-affected DRGs in selected areas will be 
compiled for all necessary care from admission to ninety days after.74 All 
providers are paid in the normal manner.75 Every year during the five year 
project, hospitals will be assigned a target price for each DRG.76 These target 
prices will be stratified to account for the higher prices that naturally accrue to 
patients with fractures needing emergent, more expensive care, as opposed to 
elective cases.77 The regional cost of treatment will account for one-third of the 
 
authority by requiring providers in the designated markets to participate in the program, failed to 
adequately engage stakeholders in the design and implementation of the program, and that the 
program amounts to a medical experiment conducted without patient consent. As of the writing of 
this article, there has been no official response from CMS. It is important to note that the main 
author of that letter, Tom Price, later served as the Secretary of Health and Human Services. In that 
capacity he exercised enormous authority of how the program was administered. Letter to Andrew 
Slavitt & Patrick Conway, Ctrs. for Medicare & Medicaid Servs. (Sept. 29, 2016), https://c.ymcdn. 
com/sites/www.clinicalresearchforum.org/resource/resmgr/docs/news_&_announcements/ccts/ 
CMMI_Letter_Final.pdf. 
 70. MS-DRG 469 (Major joint replacement or reattachment of lower extremity with major 
complications or comorbidities) or 470 (Major joint replacement or reattachment of lower extremity 
without major complications or comorbidities). See Comprehensive Care for Joint Replacement 
Model, CTRS. FOR MEDICARE & MEDICAID SERVS. (Dec. 22, 2017), https://innovation.cms.gov/in 
itiatives/CJR (last visited Feb. 8, 2018). 
 71. See Melanie Evans, Knee and Hip Bundled-Payment Challenge Is About to Start, MOD. 
HEALTHCARE (Mar. 26, 2016), http://www.modernhealthcare.com/article/20160326/MAGAZINE 
/303269996 (last visited Feb. 8, 2018). 
 72. Id. 
 73. Id. 
 74. See U.S. DEP’T OF HEALTH & HUMAN SERVS., PUB. 100-19 DEMONSTRATIONS, 
TRANSMITTAL 140 1 (Feb. 19, 2016). 
 75.  See Doherty, supra note 56, at 138; CTRS. FOR MEDICARE & MEDICAID SERVS., supra 
note 20. 
 76. See CTRS. FOR MEDICARE & MEDICAID SERVS., COMPREHENSIVE CARE FOR JOINT 
REPLACEMENT (CJR) MODEL: PROVIDER AND TECHNICAL FACT SHEET, THE CENTER FOR 
MEDICARE AND MEDICAID INNOVATION 4 (2015), https://innovation.cms.gov/Files/fact-sheet/cjr-
providerfs-finalrule.pdf. 
 77. Social Security Amendments of 1983, Pub. L. No. 98-21, 97 Stat. 65 (codified as amended 
at 42 U.S.C. § 1395ww(d) (2012)); see Doherty, supra note 56, at 138; CTRS. FOR MEDICARE & 
MEDICAID SERVS., supra note 20; Evans, supra note 71. 
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calculated target price in the first year of the demonstration but will solely 
determine the target in years three, four, and five.78 
At the conclusion of each performance year, the actual spending and quality 
metrics are compared to the targets.79 If the aggregate episodes of care fell under 
targets (if they cost less), the hospital could receive a bonus.80 However, if the 
episodes equaled more than the target price, the hospital could be forced to 
reimburse some portion of the difference.81 Hospitals are exempt from penalties 
during the first year.82 The program does place a cap on potential bonuses and 
penalties.83 For the first program year, participants will be held harmless and 
excused from potential repayments if the aggregate cost of care exceeds the 
target price.84 Beginning in the second year, repayment of overage will be 
capped at five percent.85 That figure rises to ten percent in year three, and twenty 
percent in years four and five.86 These caps limit the potential shock as providers 
make the necessary adjustments. Reconciliation payments from CMS to the 
provider are capped at five percent in years one and two.87 These caps rise to ten 
percent in year three and twenty percent in years four and five.88 
Quality is measured using a complicated composite score consisting of 
measures of medical outcomes and patient satisfaction.89 Medical complications 
within the ninety day window, such as acute myocardial infarction, pneumonia, 
sepsis, bleeding, pulmonary embolism, mechanical complications related to the 
prosthetic, and related infections, are factored into the measure.90 The score 
includes patient satisfaction domains as captured by eleven measures of the 
Hospital Consumer Assessment of Healthcare Providers and Systems 
(HCAHPS) Survey.91 The model also allows for the “voluntary submission of 
Patient Reported Outcomes (PRO)” data.92 Through a complicated scoring 
formula, individual hospital quality measures will be weighted and compared 
 
 78. Evans, supra note 71. 
 79. CTRS. FOR MEDICARE & MEDICAID SERVS., supra note 30. 
 80. Id. 
 81. Id.; see also CTRS. FOR MEDICARE & MEDICAID SERVS., supra note 20. 
 82. Evans, supra note 71. 
 83. Id. 
 84. 42 C.F.R. § 510.305 (2016). 
 85. Id. 
 86. Id. 
 87. Id. 
 88. Id. 
 89. CMMI Comprehensive Care for Joint Replacement Model: Quality Measures, Voluntary 
Data, Pub. Reporting Processes for Preview Reports, CTRS. FOR MEDICARE & MEDICAID SERVS. 
1 (2016), http://www.wsha.org/wp-content/uploads/CJR-Medicare-Quality-Fact-Sheet.pdf. 
 90. Id. 
 91. Id. at 2. 
 92. Id. at 4. 
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against national averages.93 Those hospitals with better quality scores will be 
given a “discount” off of the overall cost of their procedures proportional to 
where they rank nationally.94 This will have the practical effect of making those 
hospitals then appear more efficient from a cost standpoint.95 
As the hospital bears the exposure to cost overruns for physicians and 
skilled/home nursing care, it is imperative it find ways to curb these costs as 
well. Nursing homes in particular are fertile ground for finding new efficiencies. 
In a 2015 study of joint replacement costs using three years of Medicare data, 
researchers found a $10,000 average difference between the highest and lowest 
cost providers in three northeast states. Nursing home spending accounted for 
sixty percent of this cost difference.96 This finding demonstrated the variability 
in the cost of skilled nursing care in those markets.97 As will be discussed later, 
hospitals are finding new ways to select and work with post-acute providers 
across the spectrum of services. 
As post-acute care ideally represents the back end of the episode of care, 
physicians represent the front end. It is the physician (in this case, most likely 
an orthopedist) that orders the joint replacement and initiates the episode of care. 
Playing such a key role in the process, it would make sense that these clinicians 
have the ability to share in any potential reconciliation payments as well, beyond 
their normal Medicare Part B reimbursement. The CJR model allows for 
“collaborator[s]”98 to enter into a Participation Agreement that allows for the 
sharing of cost savings and reconciliation payments made pursuant to the 
program.99 Historically, these payments would have been prohibited by Section 
1128A(b)(1) of the Social Security Act, which prohibited a hospital from 
“making a payment, directly or indirectly, to induce a physician to reduce or 
limit services to Medicare or Medicaid beneficiaries under the physician’s 
 
 93. Id. at 17. 
 94. CTRS. FOR MEDICARE & MEDICAID SERVS., supra note 89, at 17–18. 
 95. Id. at 18. 
 96. Evans, supra note 71. 
 97. Id. 
 98. Hospital collaborators are not limited to physicians; they include “skilled nursing facilities 
(SNF),” “home health agencies (HHA),” “long-term care hospitals (LTCH),” “inpatient 
rehabilitation facilities (IRF),” and “physician group practices (PGP).” See 42 C.F.R. § 510.2 
(2017). Non-physician practitioners, as well as providers and suppliers of therapy services, are also 
included. Id. It should be noted that hospitals may not enter into gainsharing arrangements with 
certain organizations that are neither providers nor suppliers. See id. § 510.500. 
 99. Id. § 510.2. 
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care.”100 Hospitals and physicians involved in these payments are liable for a 
$2,000 civil monetary penalty (CMP) per patient.101  
One researcher pointed out the CMP could stand as perhaps the most 
significant regulatory hurdle to successful implementation of value-based 
payment models.102 The law did not distinguish between “medically necessary” 
and/or “medically unnecessary care.”103 The CJR program did specifically 
waive restrictions on gainsharing payments that are spelled-out in sharing 
agreements.104 It is worth noting that the CJR program requires that the decision 
of hospitals to enter into sharing agreements must be made, in part, on the quality 
of care to be delivered to the beneficiary during the episode.105  
In addition to specific waiver of gainsharing provisions in the CJR, an even 
larger development came when MACRA106 inserted a key qualifier into the 
statutory language. MACRA inserted the words “medically necessary” into the 
CMP statute after “reduce or limit.”107 This allows for payments to physicians 
to induce the limitation of unnecessary services. This provision is seen as an 
entrée for providers to enter into gainsharing agreements outside of waived 
demonstration projects.108 The provision in MACRA does not completely render 
moot any discussion of the compliance implications of gainsharing in general, 
or in bundled payment programs specifically.109 Commentators do see this as a 
move by CMS to reserve gainsharing enforcement to those instances where 
physicians are limiting necessary services.110 However, given its recency and 
 
 100. Special Bulletin: Gainsharing Arrangement & CMPs for Hospital Payments to Physicians 
to Reduce or Limit Services to Beneficiaries, DEP’T OF HEALTH & HUMAN SERVS., OFFICE OF THE 
INSPECTOR GEN. (1999), https://oig.hhs.gov/fraud/docs/alertsandbulletins/gainsh.htm (last visited 
Feb. 9, 2018). 
 101. Id. 
 102. Corbin Santo, Walking a Tightrope: Regulating Medicare Fraud and Abuse and the 
Transition to Value-Based Payment, 64 CASE W. RES. L. REV. 1377, 1392 (2014). 
 103. Change in CMP Law Affecting Gainsharing Arrangements, STEVENS & LEE (May 4, 
2015) (emphasis added), http://www.stevenslee.com/change-in-cmp-law-affecting-gainsharing-ar 
rangements/ (last visited Feb. 9, 2018). 
 104. CTRS. FOR MEDICARE & MEDICAID SERVS., NOTICE OF WAIVERS OF CERTAIN FRAUD & 
ABUSE LAWS IN CONNECTION WITH THE COMPREHENSIVE CARE FOR JOINT REPLACEMENT 
MODEL (Jan. 1, 2018), https://www.cms.gov/Medicare/Fraud-and-Abuse/PhysicianSelfReferral/ 
Downloads/2017-CJR-Model-Waivers.pdf. 
 105. Id. 
 106. Medicare Access and CHIP Reauthorization Act of 2015, 42 U.S.C. § 1305 (2015). 
 107. STEVENS & LEE, supra note 103. 
 108. Revisions to the CMP Law Open the Door for Gainsharing Arrangements with Physicians, 
KUTAK ROCK (May 6, 2015), http://www.kutakrock.com/revisions-cmp-gainsharing-arrangement-
physician/ (last visited Feb. 9, 2018); STEVENS & LEE, supra note 103. 
 109. KUTAK ROCK, supra note 108. 
 110. Thomas E. Dutton et al., Congress Amends Gainsharing Civil Monetary Penalties and 
Commissions Further Study of Gainsharing Agreements, JONES DAY 2 (2015), http://www.jones 
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the uncertainty surrounding how CMS will ultimately enforce the updated 
provision, it will not be addressed further in this article. 
IV.  COMPLIANCE IMPLICATIONS OF CJR MODELS 
This section will examine the relationship between financial and treatment 
arrangements fostered by CJR and traditional health care compliance statutes. 
The analysis will begin with a discussion of the waivers put in place by CMS in 
order to prevent the program from violating fundamental provisions of the health 
care regulatory framework. A discussion of typical arrangements being put 
together by providers and where these waivers are proving to be ambiguous or 
failing to address these arrangements will follow. Finally, this article will 
examine the implications and impacts of CJR preferred provider networks on 
existing SNF steering regulations. 
A. CJR Compliance Waivers 
Congress has provided the Center for Medicare & Medicaid Innovation 
(CMMI) with the authority to waive select fraud and abuse laws in order to 
facilitate the implementation of payment model demonstrations that would 
violate those laws.111 Such waivers will be discussed below in the context of the 
respective statutes.  
It should be noted that each of the fraud and abuse laws discussed also have 
the possibility of implicating the federal False Claims Act (FCA), which makes 
it a crime to knowingly present, or cause to be presented, a false or fraudulent 
claim for payment or approval.112 The FCA has a long history in United States 
law outside of health care. It was first enacted to punish war profiteers during 
the Civil War in 1863.113 Because the basis for a FCA violation is the underlying 
false or fraudulent claim, it is not subject to waiver.114 The scrutiny turns 
primarily to the legality of the underlying claim.115 If that claim is legal, either 
by its nature, or by effect of a waiver, the claim is not false or fraudulent and 
would not form the basis for an FCA action.116 
 
day.com/files/Publication/a1d72edd-58e5-476b-a072-a611289dc63c/Presentation/PublicationAt 
tachment/f426c3aa-386b-4a7e-85f1-b404234f158e/Congress%20Amends%20Gainsharing.pdf. 
 111. Social Security Act § 1115, 42 U.S.C. § 1315a (2012). 
 112. 31 U.S.C. § 3729(a)(1) (A-C) (2006). 
 113. AMY BAILEY ET AL., HEALTH CARE COMPLIANCE LEGAL ISSUES MANUAL 216 (Harry R. 
Silver & Cynthia F. Wisner eds., 4th ed. 2014). 
 114. Does a Release Signed by an Employee Preclude Whistleblowing?, MCELDREW YOUNG, 
https://www.mceldrewyoung.com/whistleblower/release/ (last updated Feb. 8, 2018); see generally 
BAILEY ET AL., supra note 113, at 223–26. 
 115. See generally BAILEY ET AL., supra note 113, at 223–26; MCELDREW YOUNG, supra note 
114. 
 116. See generally BAILEY ET AL., supra note 113, at 215. 
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One important aspect of the FCA to discuss is the liability that attaches not 
only to the person submitting the false or fraudulent claim, but to anyone who 
causes a false claim to be presented.117 This aspect of the law has been applied 
in a wide variety of ways. For example, pharmaceutical companies that promote 
off-label118 use of their drugs may cause a pharmacy to file fraudulent cost 
reports for prescriptions filled to Medicare patients because Medicare does not 
pay for off-label use.119 A widely-known example is a medical device 
manufacturer who advised hospitals to perform the device implantation as an 
inpatient procedure rather than as a medically acceptable, and less expensive, 
outpatient service.120 Almost 100 hospitals in the United States have settled FCA 
cases with the Department of Justice (DOJ) over inpatient claims they 
submitted.121 The device manufacturer itself settled the case for seventy-five 
million dollars.122 
Again, assuming that CMS waivers are sufficient and providers adhere to 
the strictures, the FCA should not be implicated. However, as this is a 
demonstration project, the idea is to push the boundaries of common practice. 
One of the most attractive and promising ways to implement bundled payment 
models is to increase collaboration among and between agencies. Providers, 
especially smaller organizations without sophisticated legal departments or the 
resources to pay large settlements, may be somewhat reticent to enter into novel, 
untested, payment arrangements for fear of being caught in a stream of FCA 
liability. In fact, there is a general climate of uncertainty following the decision 
in Universal Health Services v. United States ex rel. Escobar in which the 
Supreme Court affirmed the theory of implied certification of Medicare 
claims.123 While a thorough discussion of Escobar is outside the scope of this 
 
 117. 31 U.S.C. § 3729(a)(1)(A-B) (2006) (emphasis added). 
 118. Off-label use is the use of a prescription drug for purposes other than that for which it has 
been approved by the Food and Drug Administration. Richard C. Ausness, “There’s Danger Here, 
Cherie!”: Liability for the Promotion and Marketing of Drugs and Medical Devices for Off-Label 
Uses, 73 BROOK. L. REV. 1253, 1254 (2007). 
 119. Id. at 1284–1326. 
 120. Steven W. Postal & Robyn Whipple Diaz, DOJ’s Kyphoplasty Initiative: AHA Urges 
Greater Oversight in the Wake of Continuing Settlement Announcements, ABA HEALTH ESOURCE 
(May 10, 2011), https://www.americanbar.org/content/newsletter/publications/aba_health_e 
source_home/aba_health_law_esource_2011_may_volume_7_issue_9.html (last visited Feb. 8, 
2018); Press Release, U.S. Dep’t of Justice, Office of Pub. Affairs, 32 Hospitals to Pay U.S. More 
Than $28 Million to Resolve False Claims Act Allegations Related to Kyphoplasty Billing (Dec. 
18, 2015), https://www.justice.gov/opa/pr/32-hospitals-pay-us-more-28-million-resolve-false-
claims-act-allegations-related-kyphoplasty (last visited Feb. 8, 2018); BAILEY ET AL., supra note 
113, at 223–25. 
 121. U.S. Dep’t of Justice, supra note 120; BAILEY ET AL., supra note 113, at 223–25. 
 122. BAILEY ET AL., supra note 113, at 223–25. 
 123. Universal Health Servs., Inc. v. United States, 136 S. Ct. 1989, 1995 (2016). Writing for 
a unanimous Court, Justice Thomas held “[FCA] liability can attach when the defendant submits a 
claim for payment that makes specific representations about the goods or services provided, but 
SAINT LOUIS UNIVERSITY SCHOOL OF LAW 
264 SAINT LOUIS UNIVERSITY JOURNAL OF HEALTH LAW & POLICY [Vol. 11:249 
thesis and its ultimate application by the DOJ and trial courts remains to be seen, 
it is seen by many as a lowering of the threshold to FCA liability.124 It is 
therefore important that the legality of the CJR arrangements, as they relate to 
those regulations that could potentially form the basis of a FCA case, be 
understood as completely as possible.  
B. The Anti-Kickback Statute 
Initially enacted in 1972, the Anti-Kickback Statute (AKS) is a criminal 
statute that prohibits individuals or entities from knowingly and willfully 
offering, paying, soliciting, or receiving bribes, kickbacks, or other 
remuneration in order to induce business reimbursement from Medicare, 
Medicaid, and other federal health care programs.125 AKS has been hailed as the 
hallmark of a federal effort to limit fraud and abuse in federal health care 
spending.126 Originally a misdemeanor,127 Congress amended the statute in 1977 
making violation a felony that carries a maximum $25,000 fine, imprisonment 
of up to five years, or both.128 In addition to the criminal consequences, violation 
of AKS will cause an automatic exclusion from federally-funded health care 
programs and potential exposure to civil liability under the FCA.129 The intent 
standard was revised in 1980 to require proof that the individual or entity acted 
“knowingly and willfully” when making the prohibited referrals.130 In 1997 the 
statue was again modified to include the potential for CMPs which lowered the 
burden of proof131 and allowed for penalties up to $50,000 for each act.132  
Because financial relationships between and among health care providers 
are extremely complex, it is quite possible that certain arrangements, although 
appearing to violate AKS, may in fact be quite proper and beneficial. Congress 
directed the Secretary of HHS to carve out these relationships from AKS 
scrutiny in the form of safe harbors.133 
An often used example of an AKS violation is one in which a medical 
laboratory pays the referring physician an “interpretation fee” for the physician’s 
 
knowingly fails to disclose the defendant’s noncompliance with a statutory, regulatory, or 
contractual requirement.” Id. The Court further held that this liability is not contingent upon 
whether compliance was expressly designated by the government as a condition of payment, and 
the result of this decision is lowering the bar for potential FCA exposure. Id. at 1996. 
 124. See generally Robert Miller, Escobar Appears to Open the Door to More “Materially” 
False Claims, 10 J. HEALTH LIFE SCI. L. 1, 6 (2016). 
 125. 42 U.S.C. § 1320a–7b(b) (2012). 
 126. Santo, supra note 102, at 1379. 
 127. THOMAS S. CRANE ET AL., WHAT IS THE ANTI-KICKBACK STATUTE? 4 (2016). 
 128. BAILEY ET AL., supra note 113, at 231. 
 129. Id. 
 130. CRANE ET AL., supra note 127, at 4. 
 131. Preponderance of the evidence as opposed to beyond a reasonable doubt. 
 132. CRANE ET AL., supra note 127, at 6. 
 133. See 42 C.F.R. § 1001.952(a)-(y) (2016). 
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time spent explaining the results to the patient.134 Because the physician has the 
obligation to explain diagnostic results to the patient as part of the standard of 
care, this payment is unnecessary.135 The payment basically serves as an 
incentive, or reward, for referring patients to that particular lab.136 These 
arrangements have the potential to color the physician’s judgement into making 
a referral based on the potential kickback, rather than on medical necessity.137 
This skewed judgment can encourage overutilization of services, which 
ultimately increases the cost of providing care.138  
Gainsharing involves a hospital knowingly making a payment to a physician 
for the purpose of inducing the physician to reduce or limit services furnished to 
Medicare and Medicaid beneficiaries under the doctor’s care.139 These type of 
arrangements are not included in any of the AKS safe harbors.140 An argument 
has been made that AKS concerns in bundled payment models could be obviated 
by simply hiring physicians as bona fide employees.141 For physicians to 
abandon private practice and for hospitals to take on expensive clinical 
employees seems like a drastic step in order to satisfy regulatory requirements 
of a narrowly-drawn demonstration project. A less dramatic step would be to use 
an existing safe harbor that allows for personal service contracts.142 
Unfortunately, the requirements for the employment safe harbor are quite 
complex.143 Furthermore, these contracts must be for a year or more and set in 
advance the compensation to be paid.144 Given the experimental nature of the 
CJR program, it would be almost impossible to set the value of the compensation 
in advance.145 Providers and physicians might be handcuffed by overly-specific 
contracts that do not take into account the innovative relationships contemplated 
under the program.  
 
 134. CRANE ET AL., supra note 127, at 13. 
 135. Bryan Murray, Informed Consent: What Must a Physician Disclose to a Patient?, 14 AM. 
MED. ASS’N J. ETHICS 563, 564 (2012). 
 136. See, e.g., Press Release, U.S. Dep’t of Justice, Blood Testing Laboratory to Pay $6 Million 
to Settle Allegations of Kickbacks and Unnecessary Testing (Apr. 28, 2017), https://www.justice. 
gov/opa/pr/blood-testing-laboratory-pay-6-million-settle-allegations-kickbacks-and-unnecessary-
testing (last visited Feb. 9, 2018). 
 137. BAILEY ET AL., supra note 113, at 231. 
 138. Id. 
 139. Id. at 35.  
 140. Santo, supra note 102, at 1401. 
 141. Id. at 1402. 
 142. 42 C.F.R. § 1001.952(d) (2016). 
 143. Santo, supra note 102, at 1404. 
 144. Id. at 1388. 
 145. Id. at 1401. 
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In order to provide regulatory breathing space for CJR, CMMI used its 
authority to waive Sections 1128B(b)(1)146 and (2)147 of the Social Security Act 
related to the federal AKS.148 The waiver is only applicable to the payment of 
gainsharing and alignment payments149 pursuant to properly structured sharing 
agreements under the demonstration project.150 It does not waive any other 
remuneration a physician might receive while participating in an innovative CJR 
model.151 For example, if a physician were provided with office space in a SNF 
in order to facilitate his seeing patients in the facility.152 This scenario is outside 
of the context of gainsharing and alignment payments and could very well 
violate AKS.153 
C. Stark Self-Referral 
During the 1980s as congressional attempts to move away from fee-for-
service models began to take effect,154 physicians sought to replace lost revenue 
by investing in laboratories, diagnostic imaging centers, and outpatient surgery 
centers where they could still bill separately for individual services provided.155 
In the Omnibus Budget Reconciliation Act (OBRA) of 1989, Congress pushed 
back against this conduct by including language which prohibited a physician156 
from referring certain “designated health services (DHSs)”157 in which they, or 
 
 146. 42 U.S.C. § 1320a-7b(b)(1) (2012) (“Whoever knowingly and willfully solicits or receives 
any remuneration (including any kickback, bribe, or rebate) directly or indirectly, overtly or 
covertly, in cash or in kind.”). 
 147. Id. § 1320a-7b(b)(2) (“Whoever knowingly and willfully offers or pays any remuneration 
(including any kickback, bribe, or rebate) directly or indirectly, overtly or covertly, in cash or in 
kind to any person to induce such person.”). 
 148. CTRS. FOR MEDICARE & MEDICAID SERVS., supra note 104. 
 149. Alignment payments flow from the CJR collaborator (e.g., physicians’ group practice) to 
the hospital in cases where the episode of care exceeded the target price and the hospital made a 
reconciliation payment back to CMS. In short, alignment payments are the opposite of gainsharing 
payments. 42 C.F.R. § 510.500(b) (2017). 
 150. CTRS. FOR MEDICARE & MEDICAID SERVS., supra note 104. 
 151. Id. 
 152. Id. 
 153. Id. 
 154. For example, the Inpatient Prospective Payment System discussed earlier. See supra Part 
II. 
 155. Santo, supra note 102, at 1379–80. 
 156. 42 C.F.R. § 411.351 (2017) (“Physician means a doctor of medicine or osteopathy, a 
doctor of dental surgery or dental medicine, a doctor of podiatric medicine, a doctor of optometry, 
or a chiropractor.”). 
 157. Id. (“[DHS] means any of the following services (other than those provided as emergency 
physician services furnished outside of the U.S.), as they are defined in this section: (1)(i) Clinical 
laboratory services. (ii) Physical therapy, occupational therapy, and outpatient speech-language 
pathology services. (iii) Radiology and certain other imaging services. (iv) Radiation therapy 
services and supplies. (v) Durable medical equipment and supplies. (vi) Parenteral and enteral 
nutrients, equipment, and supplies. (vii) Prosthetics, orthotics, and prosthetic devices and supplies. 
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an immediate family member,158 had a financial relationship.159 The basic 
premise behind this law is that physicians who stand to benefit financially from 
a referral will be more likely to make that referral without respect to actual 
medical necessity. The eponymous legislation was championed by Congressman 
Pete Stark.160 Originally focused on clinical laboratory services, the legislation 
was expanded in 1993 to include the current list of DHSs.161  
Stark Law allows for a variety of penalties including denial of payment, 
refunds of payments already made in violation, and CMPs of up to $15,000 for 
each improper bill or service and three times the amount of the improper 
payment itself.162 A CMP of $100,000 may also be imposed for each violative 
arrangement scheme that the physician or entity knows, or should know, is 
designed to assure improper referrals.163 There are a number of exceptions to 
Stark which are generally beyond the scope of this thesis.164  
Although seemingly straightforward, the definition of a “financial 
relationship” can be somewhat more complicated. At its most black-and-white, 
a direct financial relationship is one in which the parties share an actual 
ownership or investment interest.165 More difficult to define are prohibited 
compensation arrangements between the physician and the entity providing the 
DHS. A compensation agreement is defined as “any payment or other benefit 
made directly or indirectly, overtly or covertly, in cash or in kind.”166 Given the 
interdependent nature of physicians and health care providers such as hospitals, 
the term “benefit” could be any number of seemingly innocuous items or 
benefits provided for the physician during the course of their practice.167  
 
(viii) Home health services. (ix) Outpatient prescription drugs. (x) Inpatient and outpatient hospital 
services.”). 
 158. Id. (“[I]mmediate family member [means] husband or wife; birth or adoptive parent, child, 
or sibling; stepparent, stepchild, stepbrother, or stepsister; father-in-law, mother-in-law, son-in-law, 
daughter-in-law, brother-in-law, or sister-in-law; grandparent or grandchild; and spouse of a 
grandparent or grandchild.”). 
 159. 42 C.F.R. § 411.354(a)(1) (2016) (meaning a “direct or indirect ownership or investment 
interest,” or a “compensation arrangement” with an entity that provides designated health services). 
 160. Steven D. Wales, The Stark Law: Boon or Boondoggle? An Analysis of the Prohibition on 
Physician Self-Referrals, L. & PSYCHOL. REV., 2013, at 1, 2. 
 161. BAILEY ET AL., supra note 113, at 235. 
 162. Social Security Act § 1877, 42 U.S.C. § 1953nn(g)(3) (2012) (Physician Self-Referral 
Law). 
 163. Id. 
 164. 42 C.F.R. § 411.355 (2012) (providing information on exceptions). 
 165. Id. § 411.354(a)(1). 
 166. Id. § 411.351. 
 167. See Susan O. Scheutzow, Challenges to Employed Physicians’ Compensation: Direct, 
Indirect, or Unintelligible Compensation, J. HEALTH & LIFE SCI. L., Feb. 2014, at 6–7; Debbi M. 
Johnstone, Illegal Remuneration and Stark Law Issues Raised by Physician Recruitment 
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Assuming the referring physician and the hospital had in place a gainsharing 
agreement, the CJR program would, absent a waiver, violate Stark Law. The 
referring physician would receive remuneration in the form of the reconciliation 
payment as a result of the referral. There is some nuance in that the remuneration 
in the case of CJR would not be a strict one-for-one for each referral. The 
payments would be dependent on the quality of care, patient outcomes, and the 
performance of many other actors in the episode of care. However, given the 
broad application of Stark in the past, it is unlikely that such an arrangement 
would withstand scrutiny absent an affirmative waiver. As with AKS, CMMI 
used its authority to waive Section 1877(a) of the Social Security Act relating to 
physician self-referral for the CJR model.168  
Given the similarities in the provisions of Stark and AKS, the potential 
effects on CJR implementation will be discussed together. There are several 
potential sources of liability in CJR, and other EPMs, as it relates to Stark and 
AKS liability. Experts have noted the sheer complexity of the sharing 
agreement, quality requirements, and the amount of documentation that must be 
kept puts participants at risk for not satisfying the conditions of the waiver.169 
While the program is complex, the real risk comes from the program’s novelty. 
Health care providers operate in a daily environment of complex legal and 
regulatory guidelines. The real limiting factor is uncertainty regarding how these 
regulations will be enforced and the lifespan of the program. 
As discussed above, the real opportunity for gains under the CJR program, 
both in terms of lower cost and higher quality care, is manifest in the ability of 
the program to encourage collaboration along a continuum of care.170 Under 
existing models, it is tempting for participants in a patient’s care to focus on only 
those aspects of the case in which they are ethically bound, legally liable, and 
financially invested. Once the patient progresses through the case to the point 
where they are being cared for by another entity, the previous provider may 
simply shuffle them along. Similarly, providers further downstream may not 
involve themselves in the patient’s care until it becomes their instant 
responsibility. This disjointed system fosters poor coordination of care for the 
patient and poorer, more expensive, outcomes. The CJR has the potential of 
using market forces to foster increased collaboration.  
A great example of the type of collaboration that is being discussed in the 
context of CJR involves attempts to limit hospital readmissions from SNFs 
following surgery.171 Such readmissions are extremely costly and would 
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negatively impact gainsharing.172 As a result, hospitals have begun to work 
closely with SNFs to detect and correct the underlying causes of the 
readmissions.173 Some causes are clinical. For example, due to the tight margins 
many nursing homes operate under, it is difficult to recruit and retain high 
quality registered nurses (RNs).174 Many facilities rely on licensed practical 
nurses (LPNs) with less training and a higher rate of turnover. One area where 
this has been shown to affect patient outcomes is urinary catheter care. Without 
the correct training on proper procedures, a facility may experience higher rates 
of urinary tract infections, which in many cases lead to readmission to the 
hospital. Hospitals have experimented with providing training to SNF nursing 
staff on proper care.175 It is hoped that this training will provide better care and 
reduce costs. The financial incentive for the hospital is higher gainsharing 
payments.176  
Another commonly reported cause for hospital readmission is SNF staff not 
being able to accurately communicate patient status to physicians. For example, 
patients often experience medical difficulties in the middle of the night or at 
other times when physicians are not physically available.177 During these 
situations, nursing staff will contact an on-call physician by telephone to report 
the issue. If the SNF does not have twenty-four-hour RN coverage, it could be a 
LPN with less training making the phone call. If that nurse is not able to 
confidently respond to the physician’s questions related to the patient’s 
condition, the physician may simply order the patient readmitted rather than risk 
doing nothing and having the patient deteriorate. In order to mitigate this 
problem, select hospitals have experimented with training SNF nursing staff on 
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how to communicate with physicians.178 This training often involves role 
playing different scenarios, and aims to build clinical and interpersonal 
communication skills.179 Some hospitals have even flirted with the idea of 
paying for physician coverage during overnight hours. Formal research related 
to the effectiveness of this intervention is just now getting underway, but 
colloquial accounts of success are promising. 
On their face, these two examples of innovation collaborations do not seem 
to implicate the existing fraud and abuse statutes above.180 The arrangements as 
presented do not include physicians referring patients in return for any 
remuneration. The models are merely health care organizations collaborating on 
initiatives to improve the quality of care. However, given that physicians are 
included in potential gain/risk sharing, should the hospital choose to build that 
model, it would make sense that they would be involved in the post-acute care 
quality improvement as well. This increased involvement may begin to implicate 
Stark and AKS.  
Generally, a typical physician’s181 relationship with a post-acute facility is 
somewhat limited. The doctors simply follow their patients to the post-acute 
settings and “round” on the them as they would in a hospital.182 There are 
generally no contractual or personal services agreements between the facility 
and the physician. SNFs typically do not peer review, credential, or offer formal 
privileges.183 “The federal Stark Law does not impact the relationship between 
an attending physician and an LTC [Long Term Care] Provider unless there is a 
direct or indirect ownership or investment interest, or a direct or indirect 
compensation arrangement, between the attending physician and the LTC 
Provider.”184 One author noted “. . . Stark Law makes it difficult for providers to 
work together to voluntarily develop or implement various arrangements designed 
to improve health care quality and control costs, including arrangements such 
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as integrated delivery systems, pay for performance arrangements, gainsharing 
arrangements, or bundled payments.”185 While the CMS fraud and abuse statute 
waiver specifically includes payments related to the gainsharing provision of 
CJR, it does nothing to protect against liability for other potentially innovative 
arrangements.186 What if a SNF offered a referring physician free office space 
in the facility to facilitate interaction with staff and patients? Office rental has 
been a much-scrutinized target of anti-kickback enforcement and should be a red 
flag to any physician.187  
D. SNF Referral 
As discussed above, the SNF into which a patient transitions after a complete 
joint replacement can have a significant impact on the cost of the overall episode. 
In an EPM, this cost difference can have very real financial ramifications for the 
hospital.188 As such, hospitals have an interest in seeing that patients are referred 
to SNFs that meet certain quality and care parameters that will produce a better, 
more economical outcome for the patient.189 Hospitals, and the care coordinators 
who work with patients and patients’ families to select a post-acute placement, 
have long been thought to “steer” patients into certain facilities.190 There are 
several reasons for why a care manager would guide patients to choose certain 
facilities. On an individual level, the care manager may just feel that one facility 
is simply better than others. If this opinion is based on objective measures, 
particularly where a patient has a unique set of needs such as Alzheimer’s care, 
that guidance would be within the professional judgment of the care manager. 
However, it could be that a particular nursing facility simply has a strong 
marketing department. It is also possible that the care manager receives gifts or 
other gratuities from the nursing home in exchange for favorable referrals. From 
an institutional level, hospitals may encourage care managers to refer patients to 
facilities that are owned by the hospital. 
To limit the practice of steering patients, federal law provides that the 
referring discharge plan “shall not specify or otherwise limit the qualified 
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provider which may provide post-hospital home health services.”191 Many 
providers took this to mean that the patient was simply to be provided with an 
alphabetical list of facilities and left to make a decision alone.192 In fact, many 
care managers took it as a matter of professional duty that they not appear to 
favor one SNF over another or risk subverting the patient’s autonomy in care 
decisions.193 The statute went on to say that care managers must inform patients 
if they are being referred to a facility “in the hospital has a disclosable financial 
interest.”194 As a response to CJR and EPMs in general, hospitals have begun to 
form preferred networks of post-acute providers in order to exercise some 
control over the quality and cost of facilities into which their patients are 
referred.195 The question is whether the creation of “preferred networks” is 
tantamount to patient steering.  
Providers are being given very mixed messages on the legality of this 
practice. The notice of waivers associated with the program simply reinforces 
the existing prohibition against steering and refers readers to the Final Rule.196 
The Final Rule itself does not provide a definitive response. Language in the 
Federal Register discussion of the Final Rule states:  
Nothing in this final rule alters the [Conditions of Participation] CoPs and 
similar requirements for providers and suppliers that furnish services to CJR 
beneficiaries. If a participant hospital or its CJR collaborator is found to have 
taken any action that threatens the health or safety of patients, including but not 
limited to…steering beneficiaries to certain providers or suppliers, this final 
rule allows CMS to take action against the participant hospital that is 
noncompliant or has a collaborator agreement with the noncompliant entity.197 
However, that same entry in the Federal Register also tactility condones the 
practice: 
Physicians and hospitals may identify and recommend ‘‘preferred providers,’’ a 
term used to include both providers and suppliers, which may include but are 
not limited to CJR collaborators with sharing arrangements with the 
participating hospital, as long as such recommendations do not result in 
violations of current laws or regulations.198 
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It is “sheer torture of the English language”199 to suggest there is a discernable 
difference between the prohibited “steering” and the permitted “identify and 
recommend.” This difference becomes even murkier when one considers that 
patients and families look to care managers for guidance in these situations and 
are very likely to defer to their advice.200 The ambiguity between these terms 
was given voice at a meeting of the Medicare Payment Advisory Commission 
(MEDPAC) with a rather protracted discussion of what was referred to as “soft 
steering,” which was acknowledged to take place.201  
V.  CONCLUSION 
There is a distinction between the legacy fee-for-service payment models of 
Medicare reimbursement and the emerging value-based payment models. 
Concomitant to that discussion was an examination of fraud and abuse statutes 
that were designed to control waste of federal health care dollars by limiting 
financial relationships between providers. These limitations were necessary 
safeguards as providers sought to make up revenue lost through cuts to 
reimbursement rates. The theory was that providers would form relationships as 
a way of increasing the volume of services that they themselves could not 
provide and bill for individually.  
Although found under a variety of names (e.g., bundled payment, EPM, fee-
for-value, value-based care), the emerging reimbursement models turn 
traditional fraud and abuse concerns upside down. Instead of being wary of 
provider relationships, the field has come to understand that fostering these 
relationships may be the key to actually reducing health care spending. In fact, 
these models actually provide financial incentives to form relationships.  
Left in the middle of this revolution are providers as diverse as large, multi-
state integrated health care networks and small primary care providers. They 
face widely divergent rules based on the type of patient they see, type of 
procedure they perform, and geographic market they serve. Although CMS has 
attempted to selectively waive fraud and abuse provisions as they deem is 
appropriate, the wide variety of providers and approaches have demonstrated 
areas where these waivers have fallen short. These gaps should not be viewed as 
a failing on the part of regulators. They themselves face a daunting challenge of 
encouraging innovation on the part of providers while at the same time 
prohibiting the creation of practices that would encourage fraud, waste, and 
abuse. Just as providers are trying to guess what CMS will allow, CMS is trying 
to guess where providers may try to game the system. The uncertainty around 
these programs will most likely increase as health care reform continues to be 
politicized. 
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The best-case scenario for the future of EPMs is that their efficacy be 
determined by independent, thorough, and rigorous research. Assuming they are, 
as many say, the future of federal health care payment, they should be introduced 
across the system in a deliberate and thoughtful manner allowing for the system 
to react appropriately. Once this transition is in progress, Congress and the 
executive branch agencies need to take a close look at fee-for-service fraud, 
waste, and abuse regulations and adjust those in a manner that guards against 
improper relationships for private-pay clients but still allows for innovative 
programs to flourish out of the public fisc.  
  
 
